. Author manuscript; available in PMC: 2015 Feb 1.

Published in final edited form as: Pharmacol Biochem Behav. 2013 Dec 18;117:118–127. doi: 10.1016/j.pbb.2013.12.014

Table 1.

Mean body weight for each treatment group at three different time points during the study.

Treatment Group	Pre-Chronic (PD 35)	Post-Chronic (PD 115)	Final (~PD 300)
Intact/Saline	132.6 ± 2.3^a	226.6 ± 4.8^b	272.6 ± 5.5^c
Intact/THC	127.2 ± 3.6^a	236.7 ± 6.2^b	275.6 ± 5.4^c
OVX/S0aline	132.8 ± 4^a	244.3 ± 5.2^b	299.3 ± 7^c
OVX/THC	138.7 ± 3.8^a	233.8 ± 9.6^b	278 ± 9.6^c

For each treatment group, superscript letters indicate significant differences among the three time points (e.g., mean group weights designated with a superscript “a” are similar to each other, but significantly different from “b” and “c”).